Börsipäev 22. juuni
Kommentaari jätmiseks loo konto või logi sisse
-
Kes ütles, et Biotehnoloogią ei ole kunagi easy money?
EYET rallib nii, et vähe pole. -
Before the Bell - Eyetech jumps on sales forecast
Wed Jun 22, 2005 07:53 AM ET
NEW YORK, June 22 (Reuters) - Shares of Eyetech Pharmaceuticals Inc. (EYET.O: Quote, Profile, Research) jumped about 6 percent before the bell on Wednesday after the company raised its full year sales forecast for its Macugen vision loss treatment [ID:nWEN3668].
The company now expects full-year revenue from Macugen of $175 million to $190 million, up from a previous forecast of $135 to $150 million. -
Gapping Up
JBL +6.2% (reports MayQ), ELOS +5.3% (CIBC sees EPS upside on recent FDA approval for VelaSmooth), EYET +5.1% (raises full-year sales forecast for Macugen), FRO +5%, FCEL +4.6% (CNBC appearance), SAP +3.1% (positive analyst/press comments), GTK +2.4% (reports MayQ, beats by $0.03), NYER +13%.... Under $3: GNLB +65% (gets confirmation of orphan drug designation for Prestara), RMKR +31% (selected by large software provider for a new client engagement), GNBT +20% (signs a research collaboration agreement with Stallergene), PPHM +12% (positive clinical data), CNXT +10% (Wachovia upgrade).
Gapping Down
CKXE -18% (prices 20 mln share offering), LEXR -5.4% (court delays decision), F -3.3% (guides lower), KR -2.3% (JP Morgan downgrade), ZMH -2%, CTTY -17% (profit taking after 312% move yesterday), VISGE -10% (UBS downgrade), CTIB -10% (profit taking after 67% move yesterday), UTSI -8%, COGT -1.6% (prices follow-on offering). -
Sai siin ostetud pärast suurt langust EYET'i 17.5 Jul CALL optsioone. 11$ Taseme juures käis mõte peast läbi, et ostan juurde.
Mõtteks see jäigi. Eks ootame kuni lendab 20$'ni välja, siis saab hea kasumiga call'id maha müüa. -
Rev Shark:
Set Up for a Breakout -- but It Could Be a Trap
6/22/05 8:07 AM ET"The obstacle is the path."
-- Zen saying
The major indices have been consolidating for the last several days right under key overhead resistance areas. The Nasdaq in particular is on the brink of overcoming a major obstacle at the 2100 level. It has failed at that level back in February, March and early this month. There is now a very bullish-looking cup-and-handle pattern that is a perfect setup for a move higher.
The obvious strategy is to buy the breakout. Many have set buy stops to be triggered upon a breach of 2100, and many others will look to put more money to work at that level. After all, it should be clear sailing to the upside once we manage to close above that very tough resistance. That sure seems pretty darn simple, but is the market ever that easy and cooperative?
While a breakout sure looks appealing here, we also have the ideal conditions for a "bull trap." A bull trap is simply a situation where the bulls are induced to buy, and then once they are heavily long, we reverse quickly and leave them trapped. A failed cup-and-handle breakout is a classic bull trap.
My feeling is that we have a very high risk of a bull trap scenario at this point. The buyers have been very tenacious lately and seem to be highly confident that a breakout is on the horizon. They are buying in anticipation of the break, and that means there will be fewer buyers to propel a move if and when the breakout occurs. When everyone in the market is looking for the same thing to occur, they tend to undermine its success when it does occur.
A couple other things should keep us watchful for the possibility of a failed breakout. The way the market has shrugged off accelerating crude oil prices suggests that it is simply delaying the day of reckoning. Some market participants believe the market's strength in the face of higher energy prices is a sign that such prices are unsustainable. Perhaps, but this belief is based more on hope than fact, and if we don't see oil pull back soon, it will take a toll on the market.
Yes, the market looks set up nicely to break out, but the chances of a failed breakout and a bull trap are also extremely high. If we break out and then falter, the reversal could be quite dramatic. Keep that in mind as you consider the action today.
We have some energetic action in the early going. Asian markets were higher overnight, mainly because of an upgrade by Lehman of the telecom chip sector. European markets are also acting well. Oil and gold are down, and the dollar is mixed.
Gary B. Smith:
-
Huh, EYET 'ile jääb Lucentise vari ikkagi, lühiajalisest positiivsusest hoolimata.
-
Alates 25 Aprill 2005 on WLDA liikunud ainult t6usujoones, tana siis jalle +3%.
2PM on miski presentatsioon. -
NITE Knight Trading: Floor Talk that large market makers could be targets as investment firms fight for institutional flow (7.93 +0.21)
NITE'l on kokku $576 mln eest raha ja likviidseid investeeringuid, mis annab aktsia kohta $5.12. Põhimõtteliselt siis muud operatsioonid $2-3 eest. Nende hulgas USA ning ilmselt ka maailma suurim turutegija ning suhteliselt edukas hedge-fond Deephaven.
Suured investeerimispangad on viimastel aastatel järjest enam kauplemistuludest sõltuma hakanud ning see muudab NITE ülevõtmiskandidaadiks.
LHV Pros on sellest veidi pikemalt.
-
Supervalu (SVU) on päris kena graafikuga. Konkurendid SWY ja KR on päris tigedalt juba rallinud ning sulgumine 33.25 peal märgiks piisavat jõudu, et veelgi edasi liikuda. Not advice.
sB
